Quotient Sciences Announces Multimillion-Pound Investment in Drug Substance Manufacturing Facility

Read article


BioNow Oncology Conference

4 November 2021

Meet up with Quotient Sciences' CSO, Dr Peter Scholes at the BioNow Oncology Conference taking place on Nov. 4th at the Alderely Park Conference Centre in the UK. 

Peter will also be presenting on the panel at 1:20pm entitled: "Bioavailability, Drug Delivery and Formulation", along with Agility Life Sciences, Seda Pharmaceutical Development Services, and N4 Pharma.

Session Chair: Claire Thompson, CEO, Agility Life Sciences
-Claire Patterson, Senior Principal Scientist, Seda Pharmaceutical Development Services
-Melody Janssen, Program Manager, N4 Pharma
-Peter Scholes, Chief Scientific Officer, Quotient Sciences

To schedule a meeting with Peter at the event, email:

Event Details:

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.